抗抑郁药不补充作为电子健康记录中药物可接受性的代理措施
Jorge A Sanchez-Ruiz1, Melissa Solares-Bravo1, Gregory D Jenkins2
1Department of Psychiatry & Psychology.
Journal of clinical psychopharmacology
|April 7, 2025
概括
连接到电子健康记录 (EHR) 的生物库可以促进药物基因组研究. 抗抑郁药物非补充是预测治疗反应和细胞染色体P450 (CYP) 相互作用的有希望的EHR衍生的结果指标.
科学领域:
- 药物基因组学 药物基因组学
- 临床信息学 临床信息学
- 精神病学是一个精神病学.
背景情况:
- 药物基因组研究需要来自电子健康记录 (EHR) 链接的生物库的强有力的结果测量.
- 目前的EHR数据缺乏针对抗抑郁药治疗结果的标准化措施.
- 为推进个性化医学的发展,开发来自EHR的结果指标至关重要.
研究的目的:
- 定义和评估来自EHR的抗抑郁药结局指标.
- 探索这些措施在药物遗传学研究中的有用性.
- 调查细胞P450 (CYP) 代谢器表型与抗抑郁药治疗结果之间的关联.
主要方法:
- 利用了与EHR相关的RIGHT 10K研究队列的数据.
- 计算了抗抑郁药反应的三个代理措施:PHQ-9分数变化,最长的单一抗抑郁药治疗持续时间和抗抑郁药不补充.
- 在欧洲祖先参与者中测试了基于处方的结果和DNA预测的CYP代谢器表型之间的关联.
主要成果:
- 鉴定了3920名服用抗抑郁药的参与者;由于缺少数据,PHQ-9结果测量是不可行的.
- 抗抑郁药物非补充措施重现了已知的抗抑郁药物-CYP相互作用.
- 研究结果仅限于具有非正常代谢体表型的小小组.
结论:
- 来自结构化EHR数据的抗抑郁药非补充,显示出作为生物库的结果指标的希望.
- 这项测量部分证实了现有的抗抑郁药-CYP相互作用.
- 需要更大的数据集来验证其在药物基因组学研究中的有用性.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
170
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
170
01:25Antidepressant Drugs: Overview
330
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
330
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
243
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
243
01:54The Placebo Effect
6.1K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.1K
01:30Electroconvulsive Therapy
19
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
19
01:28Drug Therapy
32
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
32